Association of British Clinicial Diabetologists
Autumn Meeting
BMA House in London
8th & 9th November 2018
1 Similar Variability of Fasting and 24-h Self-Measured Plasma Glucose (SMPG) with Insulin Glargine 300 U/mL (Gla-300) vs Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve Adults with T2DM: the Randomised BRIGHT Trial Ritzel R1, Cheng A2, Bosnyak Z3, Boëlle-Le Corfec E3, Cali A4, Wang X5, Frias J6, Roussel R7, Bolli GB8.
1) Klinikum Schwabing, Städtisches Klinikum München GmbH, Munich, Germany
2) Department of Medicine, University of Toronto, Toronto, Canada
3) Sanofi, Paris, France 4) Sanofi, Tokyo, Japan 5) Sanofi, Beijing, China 6) National Research Institute, Los Angeles, California, USA 7) INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France 8) Perugia University School of Medicine, Perugia, Italy 2 Impact of Background Antihyperglycaemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with T2DM from the BRIGHT Randomised Study Roussel R1, Rosenstock J2, Pettus JH3, Ritzel R4, Cheng A5, Bosnyak Z6, Devisme C7, Cali A8, Wang X9, Bolli G10
1) INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
3 BRIDGING THE GAP: PILOTING INTEGRATED CLINICAL HEALTH PSYCHOLOGY AND YOUNG ADULT DIABETES SERVICES IN WREXHAM
4 More patients achieved composite reductions of ≥1% HbA1c, ≥5% body Gowri Subramanian1, Kathleen Dungan2, Vanita R Aroda3, Filip K Knop4, Lawrence A Leiter5, Nanna L Lausvig6, Søren Lindberg6, Juris Meier7
1) Novo Nordisk Ltd., Gatwick, UK;
2) The Ohio State University, Columbus, OH, USA;
3) MedStar Health Research Institute, Hyattsville, MD, USA;
4) Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark;
5) Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada;
6) Novo Nordisk A/S, Søborg, Denmark;
7) Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany |
